TuHURA BIOSCIENCES, INC./NV Operating Leases, Rent Expense
TuHURA BIOSCIENCES, INC./NV (HURA) reported Operating Leases, Rent Expense of $40.00 thousand for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-09-28
- TuHURA BIOSCIENCES, INC./NV operating leases, rent expense for fiscal 2021 was $40.00K, a 0.00% change from fiscal 2020.
- TuHURA BIOSCIENCES, INC./NV operating leases, rent expense for fiscal 2020 was $40.00K, a 24.42% decline from fiscal 2019.
- TuHURA BIOSCIENCES, INC./NV operating leases, rent expense for fiscal 2019 was $52.93K, a 9.43% decline from fiscal 2018.
- TuHURA BIOSCIENCES, INC./NV operating leases, rent expense for fiscal 2018 was $58.43K.
| Period end | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|
| 2021-06-30 | $40.00K 10-K · filed 2021-09-28 | ||
| 2020-06-30 | $40.00K 10-K · filed 2021-09-28 | $40.13K 10-K · filed 2020-09-18 | |
| 2019-06-30 | $52.93K 10-K · filed 2020-09-18 | ||
| 2018-06-30 | $58.43K 10-K · filed 2019-09-09 | ||
| 2017-06-30 | $35.91K 8-K · filed 2019-06-03 | ||
| 2016-06-30 | $36.61K 10-K · filed 2017-09-27 | ||
| 2015-06-30 | $29.43K 10-K · filed 2016-09-13 | ||
| 2014-06-30 | $12.87K 10-K · filed 2014-08-28 | $23.85K 10-K · filed 2015-11-16 | |
| 2013-12-31 | $22.32K 10-K · filed 2014-08-28 | ||
| 2013-06-30 | $13.66K 10-K · filed 2014-08-28 | ||
| 2012-12-31 | $12.67K 10-K · filed 2014-08-28 | ||
| 2011-12-31 | $480.00 10-K · filed 2014-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |